Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01992926 · ClinicalTrials.gov registry record · NA
Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT01992926 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 109 participants.
The verdict
NCT01992926, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
Anemia is a common complication of chronic kidney disease (CKD). In anemia of chronic kidney disease, patients suffer from low hemoglobin levels, which contribute to feelings of malaise and fatigue. The current accepted practice is often to administer erythropoietin-stimulating agents (ESAs), which act like the body's natural hormones to stimulate the production of red blood cells from bone marrow. Although ESAs are widely used in CKD, recent evidence suggests that they are not as safe as previously thought. In this study, we seek to test a decision aid to be used when a patient visits his or her nephrologist at Vanderbilt. The objective of the decision aid is to reduce patient confusion, improve their satisfaction with their care, improve their knowledge of kidney disease, and ultimately bring more clarity to patients about a controversial but ubiquitous drug. The decision aid will be about 1 page long and will include questions and information that might help the patient be more active and informed regarding the choice of a course of ESA therapy. We will ask patients to answer questions before and after their clinic visits regarding their satisfaction and confidence in their treatment and their knowledge of kidney disease; we will ask some of the same questions 3 months after the clinic visit. We will compare patients who are counseled using the decision aid to patients who are not. We anticipate total experiment running time to be approximately 5 months to recruit and follow up on all patients.
Interventions
- BEHAVIORAL interactive educational intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01992926
The ClinicalTrials.gov registry entry for NCT01992926 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which interactive educational intervention is the first listed.
NCT01992926 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01992926 about?
NCT01992926 is a clinical study titled "Facilitating Anemia Treatment Risk Communication for Patients With Kidney Disease: Decision Aid Trial". Anemia is a common complication of chronic kidney disease (CKD). In anemia of chronic kidney disease, patients suffer from low hemoglobin levels, which contribute to feelings of malaise and fatigue. The current accepted practice is often to administer erythropoietin-stimulating agents (ESAs), which ...
What is the current status of trial NCT01992926?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2013-11. Estimated completion is 2014-08.
What interventions are being tested in trial NCT01992926?
The interventions under investigation include: interactive educational intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01992926?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.